Get your medical research to proof-of-concept stage
Biomedical Translation Bridge
The Biomedical Translation Bridge supports an organisation to fund and nurture early stage health and medical research ventures to reach proof-of-concept stage. With this support, we hope that the ventures have the potential to attract further capital and support. This opportunity is closed to new applications.
Closed
This grant is currently closed to applications
What do you get?
This grant provided up to $22.3 million across 4 years.
Who is this for?
Early stage health and medical research ventures were eligible to apply.
Overview
The intended outcomes of this grant opportunity were to:
- de-risk and develop ventures so that they can attract further funding
- nurture and mentor the next generation of health and medical research innovators in Australia
- develop ventures to become attractive to the Biomedical Translation Fund
This opportunity aimed to assist in developing ventures that ultimately address health problems of national significance through disease :
- prevention
- cures
- treatments
The grant provided $22.3 million over 4 years:
- $10.4 million in 2018-19
- $5.3 million in 2019-20
- $5.3 million in 2020-21
- $1.3 million in 2021-22
Need help?
Let us answer your question via phone, email or live chat. And if we can't help, we'll put you in touch with someone who can.
- Phone:
-
Open Hours:
Monday – Friday, 8am – 8pm across Australia
- Website:
Key documents
We use cookies to give you a better experience on our website. Learn more about how we use cookies and how you can select your preferences.